Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 17, 2021.
- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 17, 2021.
- Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality.
- Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA MVP.
- In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patients cancer and immune response.